Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. - Burcombe, R. J.; Makris, A.; Richman, P. I.; Daley, F. M.; Noble, S.; Pittam, M.; Wright, D.; Allen, S. A.; Dove, J.; Wilson, G. D. (British Journal of Cancer, 2005)